港股異動 | 雅高控股(3313.HK)大漲逾23% 獲納入MSCI中國指數
格隆匯11月8日丨雅高控股(3313.HK)午後漲幅進一步擴大,現大漲23.08%,報8港元,暫成交4771.89萬港元,最新總市值247.89億港元。MSCI明晟最新公佈半年度檢討結果,MSCI中國指數納入218只股份,並剔除7只股份,獲納入股份包括雅生活服務、深高速、雅高控股等,上述變動均在11月26日收市後生效。業內人士稱,今日股價明顯大漲,利好消息刺激股價上升。值得注意的是,自今年6月底股價啟動上漲以來,至9月13日創出歷史新高9.75港元,不到3個月期間一度累漲800%,但同時也遭遇暴跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.